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Alternative splicing generates multiple transcripts
from a single gene, and cell-type-specific splicing
profiles are important for the properties and func-
tions of the cells. Recently, somatic cells have been
shown to undergo dedifferentiation after the forced
expression of transcription factors. However, it re-
mains unclear whether somatic cell splicing is reor-
ganized during reprogramming. Here, by combining
deep sequencing with high-throughput absolute
qRT-PCR, we show that somatic splicing profiles
revert to pluripotent ones during reprogramming.
Remarkably, the splicing pattern in pluripotent stem
cells resembles that in testes, and the regulatory re-
gions have specific characteristics in length and
sequence. Furthermore, our siRNA screen has iden-
tified RNA-binding proteins that regulate splicing
events in iPSCs. We have then demonstrated that
two of the RNA-binding proteins, U2af1 and Srsf3,
play a role in somatic cell reprogramming. Our results
indicate that the drastic alteration in splicing repre-
sents part of the molecular network involved in the
reprogramming process.
INTRODUCTION
Alternative splicing is a posttranscriptional process in which pre-
mature transcripts are selectively cut and joined inmore than one
way to generate multiple mRNA forms from a single gene. These
different mRNAs can produce different proteins with different
functions and properties (Nilsen and Graveley, 2010). Therefore,
alternative splicing is one of themain sources of proteomic diver-
sity; such diversity may allow complex and flexible intracellular
molecular networks. It has been suggested that the transcripts
from more than 90% of human genes are alternatively spliced
in a variety of adult tissues (Pan et al., 2008; Wang et al.,
2008). Tissue- and cell-type-specific splicing patterns have
been shown to play critical roles in the intrinsic properties andCfunctions of the tissues and cells. In fact, it has been shown
that the disruption of splicing or its regulation can cause disease
and that at least 15% of all human disease mutations have an
impact on splice site selection (Cooper et al., 2009). In addition,
in embryonic stem cells (ESCs), several genes have been shown
to undergo ESC-specific splicing to ensure the specific functions
(Atlasi et al., 2008; Cheong and Lufkin, 2011; Gabut et al., 2011;
Gopalakrishnan et al., 2009; Rao et al., 2010; Salomonis et al.,
2010; Yeo et al., 2007). These findings demonstrate the physio-
logical importance of precise splicing regulation.
Induced pluripotent stem cells (iPSCs) were originally gener-
ated from somatic cells by the expression of just four trans-
cription factors (Takahashi and Yamanaka, 2006), and their
morphology, differentiation capacity, and gene expression pro-
file are almost exactly equivalent to those of ESCs (Mikkelsen
et al., 2008; Okita et al., 2007). However, it remains unclear
whether somatic splicing is reorganized during the process.
To examine changes in genome-wide splicing profiles during
the cellular reprogramming process, we combined deep
sequencing with high-throughput quantitative RT-PCR (qRT-
PCR). Our results demonstrated that iPSCs closely resemble
ESCs in their splicing profiles and, thus, indicated that somatic
splicing profiles revert to undifferentiated ones by cell reprog-
ramming. Then, to obtain mechanistic insights into the splicing
regulation in iPSCs, we performed siRNA screen for RNA-bind-
ing proteins that are responsible for the splicing regulation.
Consequently, several RNA-binding proteins that could function
as splicing regulators in pluripotent stem cells have been identi-
fied. Moreover, we have shown that downregulation of two RNA-
binding proteins, U2af1 and Srsf3, significantly suppressed the
efficiency of somatic cell reprogramming. Thus, our results
identify splicing regulation as part of the molecular network
involved in the reprogramming process and the maintenance
of pluripotency.
RESULTS
Global Analysis of Changes in Splicing Patterns during
Reprogramming
To analyze the mRNA splicing differences before and after re-
programming, we performed RNA sequencing (RNA-seq) onell Reports 5, 357–366, October 31, 2013 ª2013 The Authors 357
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mRNA from mouse embryonic fibroblasts (MEFs) and mouse
iPSCs. As a result, more than 70%of sequence reads weremap-
ped to the reference sequences. In this mapping, we obtained
approximately ten million junction reads, which spanned exon
splice junction sites, from each sample (Table S1). We used
these reads to analyze the splicing patterns (Wang et al.,
2008). Alternative splicing events were subdivided into several
types (Figure 1A). We examined six splicing event types by
comparing the ‘‘inclusion ratio,’’ which was defined as the ratio
of the read number derived from the ‘‘inclusion’’ (red) junction re-
gion, to the total number derived from the inclusion and the
‘‘exclusion’’ (blue) junction region (Figure 1A). There were 770
splicing events (587 genes), whose inclusion ratios were signifi-
cantly different (FDR <0.01) between the MEFs and iPSCs by a
minimum of 0.2 absolute change (Figure 1A; Table S2). We
next performed clustering analysis based on the inclusion ratios
and found that two iPSC lines and one ESC line showed similar
patterns for all of the splice types examined (Figures 1B and
S1A). This result indicates that the global splicing pattern of
MEF is dramatically converted into that of ESCs during iPSC in-
duction. We analyzed which biological processes and pathways
are relevant to the change in splicing during iPSC induction by
Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems,
http://www.ingenuity.com) (Figure S1B). As a result, several
biological functions and pathways including ‘‘Embryonic Devel-
opment’’ and ‘‘RNA Posttranscriptional Modification’’ are sig-
nificantly enriched in the genes whose splicing patterns are
changed during iPSC induction (Figure S1B). These results imply
that splicing switches during reprogramming are relevant to plu-
ripotency and its acquisition and that RNA posttranscriptional
regulators including splicing factors affect themselves by autor-
egulation (Lareau et al., 2007; Ni et al., 2007) and convert post-
transcriptional regulatory networks into the pluripotent state.
Splicing Patterns in Multiple iPSC Lines and ESC Lines
We focused on exon-skipping events to further analyze the
splicing regulation during iPSC induction because this type of
splicing occurs most frequently in higher eukaryotes. To validate
the alternative exon data obtained from the RNA-seq analysis,
we performed qRT-PCR. For this analysis, we used the BioMark
System (Fluidigm), which enables us to perform high-throughput
real-time qRT-PCR. We also used digital PCR to determine the
absolute expression level of each splicing variant. By combining
qRT-PCR and digital PCR (‘‘absolute qRT-PCR’’), we were able
to calculate the exact inclusion ratio (see Figure S2A) accurately
and reliably. Here, we focused on the ‘‘DNA-binding protein’’-
and ‘‘Protein kinase’’-encoding genes because many studies
have shown that these types of genes are involved in the reprog-
ramming process. In the skipped exons whose inclusion ratio inFigure 1. Identification of Gene Sets Whose Splicing Patterns Are Cha
(A) Scatterplots show inclusion ratios (IncRs) of iPSCs (492B4) and MEFs. Each op
0.5 (red and blue) or 0.2–0.5 (orange and cyan) (Fisher’s exact test, FDR <0.01).
(B) Clustering analysis of the skipped exon inclusion ratios is illustrated. The skipp
than 0.2 (Fisher’s exact test, FDR <0.01) were used.
(C) The cumulative frequencies of the lengths of the skipped exons and their su
comparing to nonaffected AS (alternative splicing), respectively.
See also Figure S1.
CMEFs is different from that in iPSCs, there were 45 and 24 genes
that are annotated in the Gene Ontology database as ‘‘DNA-
binding’’ and ‘‘Protein kinase,’’ respectively. Although several
targets could not be detected, we could examine the splicing
patterns of 38 genes by the absolute qRT-PCR method. As a
result, we could confirm that the inclusion ratio in MEFs is sig-
nificantly different from that in iPSCs (p < 0.05) in 36 out of 38
genes. Then we examined the inclusion ratio of the 36 genes in
an additional twoMEFs and six iPSC lines as well as three partial
iPSC (piPSC) lines (Okita et al., 2007) and three ESC lines to iden-
tify the genes that show a pluripotent stem cell-specific splicing
pattern. Consequently, we found that in 27 out of 36 genes, the
inclusion ratio in MEFs is significantly different from that in iPS/
ESC lines (FDR <0.05, Figures 2A and S2B). Although the inclu-
sion ratios of some genes varied among pluripotent stem cells,
our clustering analysis showed that the overall splicing patterns
of the 27 genes are similar among iPSC and ESC lines and
different from those in piPSCs and MEFs (Figure S2C; see
Supplemental Discussion). Furthermore, we confirmed that
other genes with different function (eight genes) were also alter-
natively spliced as predicted in the RNA-seq analysis and
showed similar splicing patterns in all the iPSC/ESC lines exam-
ined (Figure S2D).
Characteristics in Sequences and Lengths in and
Adjacent to Alternative Exons
Next, we set out to explore genomic signatures associated with
the splicing changes during reprogramming. First, we searched
for consensus motifs in the exons and introns within and around
the exons because specific splicing factors are thought to recog-
nize specific RNA sequences to regulate the splicing patterns.
According to our RNA-seq data, approximately 400 skipped
exons are alternatively spliced between the MEFs and iPSCs
(Figure 1A, skipped exon). We subdivided these exon-skipped
regions into two groups and investigated enriched sequences.
Each group includes exons that are preferentially expressed in
MEFs (referred to as Group_MEFinc) or in iPSCs (referred to as
Group_iPSinc). As a result, we identified several overrepre-
sented motifs within the alternatively skipped exons and the
adjacent introns in Group_MEFinc or Group_iPSinc (Figure S1C).
Thus, particular RNA-binding proteins might affect exon reorga-
nization through binding to specific RNA sequences.
We next investigated the length distribution of the skipped
exons and their surrounding introns of the two groups because
exon-intron structure can also be important for splicing regula-
tory mechanisms (Fox-Walsh et al., 2005; Sterner et al., 1996;
Yeo et al., 2007). Interestingly, the lengths of the introns sur-
rounding the Group_iPSinc exons (median, 3,083 bp) are signif-
icantly shorter, and the lengths of the introns surrounding thenged during the Somatic Cell Reprogramming Process
en circle indicates a splicing event whose inclusion ratio is changed more than
The numbers of open circles in each fraction are shown.
ed exons that differ in inclusion ratio between MEFs and ESCs (V6.5) by more
rrounding introns are shown. *p < 0.05, **p < 0.005 for Mann Whitney U test
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Group_MEFinc exons (median size, 5,056 bp) are significantly
longer than those of the expressed but nonaffected exons
(median size, 4,204 bp) (Figure 1C). In contrast, the lengths of
the Group_iPSinc exons (median size, 129 bp) are longer, and
the lengths of the Group_MEFinc exons (median size, 76 bp)
are shorter than those of nonaffected exons (median size,
105 bp) (Figure 1C). Thus, the fundamental mechanisms for the
splice site selection in pluripotent stem cells may be different
from those in somatic cells, whichmight contribute to generating
cell identities such as the stemness of pluripotent stem cells.
The Splicing Pattern in iPSCs Is Most Similar to that in
Testes
We identified the 27 genes by the absolute qRT-PCR data, which
undergo alterations in splicing pattern during the reprogramming
process. Next, to determine whether the alterations in splicing
patterns have specificity for pluripotent stem cells, we character-
ized the splicing profiles of the 27 genes across multiple tissues
by utilizing the absolute qRT-PCR. Interestingly, we found that
the splicing patterns in the iPSCs are similar to those in the testes
(Figure 2B). To confirm this observation, we performed clustering
analysis based on the inclusion ratio values from the absolute
qRT-PCR shown in Figures 2B and S2E. This analysis demon-
strated that the splicing patterns of the iPSCs were most similar
to those of the testes (Figure 2C). This result suggests that plurip-
otent stem cells may use the samemechanisms to regulate alter-
native splicing as the testes do.
Splicing Transitions during Reprogramming Are
Temporally Coordinated and Can Be Divided into
Subgroups
Previous studies demonstrated that pluripotent markers or other
genes are sequentially expressed during the reprogramming of
MEFs (Brambrink et al., 2008; Chen et al., 2010; Stadtfeld
et al., 2008). To determine whether splicing switches occur
concurrently or in sequential steps, we collected cells by FACS
(BD Biosciences) during different phases of cellular reprogram-
ming using anti-Thy1 and anti-SSEA-1 antibodies (Stadtfeld
et al., 2008). In this experiment, we used Nanog-GFP reporter
MEFs that express GFP when the endogenous Nanog promoter
is induced (Okita et al., 2007). First, according to the established
method, we fractionated Thy-1-positive Nanog-GFP reporter
MEFs 1 day before the infection with viral vectors encoding re-
programming factors (Day 1) to isolate a population homoge-
neous for Thy-1 expression as the starting material; these cells
accounted for approximately 20% of the MEF population (Fig-
ure 3A). Analyses were then conducted on day 4, 8, and 14 after
infection. qRT-PCR for Thy-1 and Nanog expression confirmed
that the sorted fractions contained correct populations (Fig-
ure S3A). The splicing transitions of the gene set were analyzedFigure 2. Characterization of Splicing Patterns in MEFs and iPSCs
(A) Splicing patterns in MEFs, three piPSC lines, seven iPSC lines, and three ESC
origin, the number of reprogramming factors, and the type of vectors that were
epithelial cell), and tail tip fibroblast (TTF). For each gene, absolute expression le
(B) Splicing patterns across multiple adult mouse tissues using absolute qRT-PC
(C) Clustering analysis of splicing patterns across multiple tissues is presented. T
See also Figure S2.
Cby examining the inclusion ratios in each sorted fraction using
the absolute qRT-PCR. The result showed that the splicing
pattern switches occur stepwise at particular points in time.
The gene set could be divided into three subgroups according
to the switch times (Figures 3B and S3B). We also compared
the splicing patterns in the sorted cells with those in piPSCs (Fig-
ures 2A and S2B). The clustering analysis showed that the
splicing patterns in piPSCs are the intermediate state in the
reprogramming process (Figure S3C). Collectively, these data
indicate that, similar to gene expression, alternative splicing is
sequentially regulated, suggesting that splicing regulation may
be tightly linked to the transcriptional regulation during somatic
reprogramming.
siRNA Screen Identifies Splicing Regulators that Play a
Role in Somatic Cell Reprogramming
To obtain mechanistic insights into the distinct splicing regula-
tion in iPSCs, we performed an RNAi screen in pluripotent
stem cells. Tissue-specific alternative splicing can be mediated
by the tissue specifically expressed RNA-binding proteins that
bind to regulatory cis elements (Licatalosi and Darnell, 2010).
Therefore, we focused our attention on the RNA-binding pro-
tein-encoding genes. According to theNEXTBIO database, there
were 501 genes that belong to the ‘‘RNA-binding’’ category in
the whole mouse genome. To identify RNA-binding protein-
encoding genes that are involved in the reprogramming process
by positively regulating alternative splicing specific for pluripo-
tent stem cells, we performed gene expression profiling by
GeneChip microarray (Affymetrix) and selected 92 genes, based
on the criterion that their expression level is at least 2-fold higher
in iPSCs/ESCs than in MEFs (Figure S4A). We then examined the
expression profile of the gene set (92 RNA-binding protein-
encoding genes) in 96 mouse tissues and cell lines using the
BioGPS public data (http://biogps.gnf.org). Consequently, the
expression profile of the gene set in ESCs was found to be
most similar to that in testes among various tissues and cell lines
(Figure S4B), as in the case of the similarity in the splicing regu-
lation between pluripotent stem cells and testes (Figures 2B and
2C), suggesting that these 92 RNA-binding protein-encoding
genes might be involved in the splicing regulation in pluripotent
stem cells. We thus generated an siRNA library that targets the
92 genes to explore siRNAs that induce differences in alternative
splicing. In our RNAi screen, each gene was targeted by a pool of
three different siRNA duplexes, and each splicing pattern was
analyzed in duplicate in both ESCs and iPSCs. First, we
confirmed that our experimental system is appropriate for
assessing the effects of RNA-binding protein depletion (Fig-
ure S4C). We next examined the effect of each siRNA pool on
the splicing pattern (the ratio between the expression levels of
inclusion forms and exclusion forms) of the genes that werelines using absolute qRT-PCR are shown. The upper table represents the cell
used for inducing each piPSC/iPSC: hepatocyte (Hep), stomach (Stm; gastric
vels (left) and inclusion ratios (right) are presented. Mean ± SD (n = 3).
R are shown. The graphs indicate the inclusion ratios. Mean ± SD (n = 3).
his analysis was based on the inclusion ratios obtained in (B) and Figure S2E.
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alternatively spliced between MEFs and iPSCs and found that
about one-third of our siRNA pools influenced the splicing pat-
terns (Figures 4B and 4C; data not shown). These siRNA target
genes would be strong candidates for the splicing regulators in
pluripotent stem cells. For nine RNA-binding protein-encoding
genes that affected the splicing patterns effectively in our initial
RNAi screen (Figure 4C), we produced retroviral-mediated small
hairpin RNAs (shRNAs) (Figures 4D, 4E, and S4I) and examined
the impact of the shRNAs on somatic cell reprogramming. We
coinfected Nanog-GFP reporter MEFs with retroviruses ex-
pressing the reprogramming factors (Oct4, Sox2, Klf4, and
c-Myc) and the shRNAs. As a result, downregulation of U2af1
or Srsf3 suppressed both the efficiency of AP-positive colony
formation (Figure 4F) and the extent of Nanog-GFP expression
(Figure 4G), although there were no obvious phenotypes such
as reduced cell division and change in morphology as long as
we observed MEFs 2 days after the shRNA infection. We also
confirmed that U2af1 and Srsf3 were upregulated at the protein
level in iPSCs compared toMEFs (Figure 4E) and that downregu-
lation of U2af1 and Srsf3 by each of the siRNA pools altered the
splicing patterns without affecting the iPSC proliferation and the
expression of housekeeping genes (Figures S4E–S4H; data not
shown). Taken together, these data suggest that U2af1 and
Srsf3 play a role in somatic cell reprogramming.
DISCUSSION
In this study, we performed global analysis of alternative splicing
and identified several hundred genes whose splicing patterns
are changed during the reprogramming process. Moreover,
our data indicate thatmolecular properties of somatic cells revert
to those of ESCs in terms of isoform expression. Although the
functional significance of each splicing variant in the reprogram-
ming process remains to be elucidated, our analysis reveals that
cellular reprogramming accompanies the drastic changes in
splicing regulation.
Our siRNA screen experiment has identified candidate RNA-
binding proteins that function as splicing regulators in pluripotent
stem cells. Moreover, our analysis showed that U2af1 and Srsf3
play a role in somatic cell reprogramming. After completion of
our work, there appeared a paper of Han et al. (2013) reporting
that two RNA-binding proteins, MBNL1 and MBNL2, whose
expression levels are much lower in pluripotent stem cells than
in many differentiated cells, play an important role in the mainte-
nance of pluripotency and cellular reprogramming by negatively
regulating alternative splicing specific for pluripotent stem cells.
In addition, our splicing analyses in this study identified the RNA-
binding protein-encoding genes whose splicing patterns are
changed during the reprogramming process (Figure S1B). Taken
together, the dynamic reorganization of the alternative splicing
profile, which occurs during somatic cell reprogramming, mightFigure 3. Splicing Pattern Transitions during Somatic Cell Reprogram
(A) FACS plots of Thy1, SSEA-1, and Nanog expression on day 4, 8, and 14 after in
expressing Oct4, Sox2, Klf4, and c-Myc were used to infect Nanog-GFP MEFs o
(B) Determination of splicing switch times during reprogramming using absolute q
numbers correspond to more reprogrammed samples. The iPS492B4 cell line w
See also Figure S3.
Cbe achieved by the quantitative and qualitative changes in the
molecular repertoire of RNA-binding proteins. In summary, our
study describes the drastic change in splicing isoform expres-
sion and its regulatory mechanisms during reprogramming and
suggests that alternative splicing regulation represents part of
the mechanisms of cellular reprogramming and has important
roles in pluripotency, although the functional relevance of
splicing during cellular reprogramming remains to be elucidated.
EXPERIMENTAL PROCEDURES
Cell Culture and iPSC Generation
Mouse iPSCs, mouse ESCs, and MEFs were cultured as previously described
(Takahashi and Yamanaka, 2006). piPSCs were cultured in the same condition
as iPSCs. See Supplemental Experimental Procedures for details. The gener-
ation ofmouse iPSCswith retroviruses was performed as previously described
(Takahashi and Yamanaka, 2006) with some modifications, which are detailed
in the Supplemental Experimental Procedures.
RNA-Seq
RNA was isolated using the RNeasy Mini Kit (QIAGEN). The polyA fraction was
selected using a magnetic-based purification kit (Dynabeads mRNA Purifica-
tion Kit; Invitrogen). The cDNA libraries for MEFs and iPSCs were generated
and sequenced with the SOLiD System (Life Technologies) according to the
instructions of the manufacturer. See Supplemental Experimental Procedures
for details.
Data Analysis
The RNA-seq data sets were mapped to both the mouse exon-exon junction
sequences that were defined by three transcript databases (i.e., RefSeq,
UCSC Known Genes, and Ensemble::Transcript) and the mouse reference
genome (mm9) using BioScope v.1.3 (Life Technologies) with default mapping
parameters. The calculation of the inclusion ratio, the statistical analysis, the
clustering analysis, and Motif analysis were performed using Microsoft SQL
server and R software with custom-made programs. The functional analyses
were generated through the use of IPA (Ingenuity Systems, http://www.
ingenuity.com).
Flow Cytometry
Cells were incubated with PE-conjugated rat anti-Thy1 (sc-52616 PE; Santa
Cruz Biotechnology) and Alexa Flour 647-conjugated mouse anti-SSEA-1
(sc-21702 AF647; Santa Cruz Biotechnology) antibodies and analyzed on a
FACSAria II instrument (BD Biosciences). Dead cells were excluded by stain-
ing with DAPI. The data were analyzed using FlowJo software (Tree Star).
RNA Isolation, qRT-PCR, Digital PCR, and Microarray Analysis
RNA was isolated using the RNeasy Mini Kit following the manufacturer’s in-
structions, and cDNA was produced using the QuantiTect Reverse Transcrip-
tion Kit (QIAGEN). qRT-PCRs were set up with SYBR Premix Ex TaqII (Perfect
Real Time) (TaKaRa) and run on a StepOne Plus QPCR System (Applied
Biosystems). For high-throughput qRT-PCR, qRT-PCRs were run using the
BioMark System (Fluidigm) following the manufacturer’s instructions. For dig-
ital PCR, cDNAwas diluted on dqPCR 37K chips, and PCRswere run using the
BioMark System following the manufacturer’s instructions. See Table S3 for
the primer sequences for qRT-PCR. For expression profiling, RNAs derived
from MEFs and iPSCs (492B4) were reverse transcribed, labeled, and
analyzed on the Affymetrix microarray (mouse Gene 1.0 ST arrays). Furtherming
fection are shown. A cutoff was set using unstained control cells. Retroviruses
n day 0.
RT-PCR is presented. The graphs indicate the inclusion ratios. Larger sample
as used as a mature iPSC sample. Mean ± SD (n = 3).
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data analysis was performed using GeneSpring GX software (Agilent Technol-
ogies). See Supplemental Experimental Procedures for details.
siRNA Screen
Silencer siRNAs (Life Technologies) for a single target gene were pooled. Then
the siRNA pools were transfected into murine iPSCs and ESCs by using
Lipofectamine 2000 (Life Technologies) by reverse transfection according to
manufacturers’ instructions. After siRNA treatment for 48 hr, cDNA was
synthesized using the Cells to CT Kit (Life Technologies). Then, real-time quan-
titative PCRs were run on the BioMark System following themanufacturer’s in-
structions. See Supplemental Experimental Procedures for details.
Immunoblotting
See Supplemental Experimental Procedures for details and antibodies used.
Public Microarray Data Analysis
The expression profiles of the 92 RNA-binding genes in tissues and cell lines
were obtained from the BioGPS public database (http://biogps.gnf.org).
ACCESSION NUMBERS
All sequencing data were deposited in the Gene Expression Omnibus under
the accession number GSE45916.
All DNA microarray data were deposited in the Gene Expression Omnibus
under the accession number GSE46149.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, four figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2013.09.016.
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